405174-46-1

Usage

Uses

Used in Pharmaceutical Industry:
2H-Pyrano[3,2-b]pyridine,3,4-dihydro-4-methylene-(9CI) is used as a potential pharmaceutical candidate for the development of new drugs. Its unique molecular structure and reactivity may contribute to the discovery of novel therapeutic agents with specific biological activities.
Used in Agrochemical Industry:
In the agrochemical industry, 2H-Pyrano[3,2-b]pyridine,3,4-dihydro-4-methylene-(9CI) is used as a potential lead compound for the design of new agrochemicals. Its structural features may be exploited to create innovative products with targeted biological effects, such as pest control or crop protection.
Further research and study are essential to fully understand the properties and potential uses of 2H-Pyrano[3,2-b]pyridine,3,4-dihydro-4-methylene-(9CI), as its current applications are based on its structural characteristics and the possibilities they present in various industries.

InChI:InChI=1/C9H9NO/c1-7-4-6-11-8-3-2-5-10-9(7)8/h2-3,5H,1,4,6H2

Upstream product

• 6602-32-0 2-bromo-pyridin-3-ol 
• 405174-45-0 2-bromo-3-(but-3-en-1-yloxy)pyridine 
• 68696-18-4 tetraethylammonium chloride monohydrate 
• 627-27-0 homoalylic alcohol 
• 3375-31-3 palladium diacetate 

Downstream Products

• 405174-47-2 4-hydroxymethyl-3,4-dihydro-2H-pyrano[3,2-b]pyridinyl-4-ol 
• 1561765-29-4 (S)-N-(4-(3-fluoro-4-(trifluoromethoxy)phenyl)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-carboxamide 
• 1561765-36-3 (S)-1-(4-(3-fluoro-4-(trifluoromethoxy)phenyl)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-3-(6-fluoropyridin-3-yl)urea 2,2,2-trifluoroacetate 
• 1561765-64-7 (S)-N-(4-(3-fluoro-4-(trifluoromethoxy)phenyl)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)benzenesulfonamide 2,2,2-trifluoroacetate 
• 1561765-70-5 (S)-N-(4-(3-fluoro-4-(trifluoromethoxy)phenyl)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)pyridine-3-sulfonamide 2,2,2-trifluoroacetate 
• 405174-48-3 2,3-dihydro-4H-pyrano[3,2-b]pyridine-4-one 
• 1561778-47-9 (S)-4-(3-fluoro-4-(trifluoromethoxy)phenyl)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-amine hydrochloride 
• 1049634-21-0 Br^(1-)*C₃₅H₃₂N₂O₂P⁽¹⁺⁾ 
• 1049634-22-1 C₄₀H₃₄N₄O₂ 
• 1049634-23-2 C₃₈H₃₂N₄O 
• 1049634-20-9 C₁₇H₁₇BrN₂O₂ 
• 754149-09-2 C₈H₉NO₂ 
• 1561778-44-6 (S)-N-((S)-4-(3-fluoro-4-(trifluoromethoxy)phenyl)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-2-methylpropane-2-sulfinamide 
• 1561777-94-3 4-(4-(trifluoromethyl)phenyl)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-ol 

Relevant academic research and scientific papers

6,7-dihydro-5H-quinoline-8-hydrazone derivative iron chelator and application in preparation of antitumor drug

The invention provides a 6,7-dihydro-5H-quinoline-8-hydrazone derivative iron chelator and its application in the preparation of an antitumor drug. Specifically, the invention provides a compound as shown in the formula I, wherein each substituent is as defined in the specification. The compound of the invention can be used as an inhibitor of tumor cell proliferation for the preparation of an antitumor drug.

HETEROCYCLIC THIOSEMICARBAZONE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS

Pharmaceutical compounds, compositions, and methods are presented in which various heterocyclic thiosemicarbazone derivatives are prepared. Contemplated compounds will be suitable to inhibit or reduce cellular growth or proliferation and are thus beneficial in the manufacture of drugs to treat neoplastic diseases.

CHROMAN DERIVATIVES AS TRPM8 INHIBITORS

Chroman compounds and derivatives of Formula I are useful inhibitors of TRPM8. Such compounds are useful in treating a number of TRPM8 mediated disorders and conditions and may be used to prepare medicaments and pharmaceutical compositions useful for treating such disorders and conditions. Examples of such disorders include, but are not limited to, migraines and neuropathic pain. Compounds of Formula I have the following structure: where the definitions of the variables are provided herein.

FUNCTIONALLY SELECTIVE AZANITRILE ALPHA2C ADRENORECEPTOR AGONISTS

In its many embodiments, the present invention provides a novel class of azanitrile compounds as inhibitors of α2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, method

DERIVATIVES AND ANALOGS OF CHROMAN AS FUNCTIONALLY SELECTIVE ALPHA2C ADRENORECEPTOR AGONISTS

In its many embodiments, the present invention provides a novel class of chroman compounds of formula I as α2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of prepaxing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the α2C adrenergic receptors using such compounds or pharmaceutical compositions.

Chemokine receptor binding heterocyclic compounds with enhanced efficacy

The invention relates to heterocyclic compounds consisting of a core nitrogen atom surrounded by three pendant groups, wherein two of the three pendant groups are preferably benzimidazolyl methyl and tetrahydroquinolyl, and the third pendant group contains N and optionally contains additional rings. The compounds bind to chemokine receptors, including CXCR4 and CCR5, and demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).